BeiGene Management
Management criteria checks 2/4
BeiGene's CEO is John Oyler, appointed in Jan 2010, has a tenure of 14.33 years. total yearly compensation is $18.93M, comprised of 4.6% salary and 95.4% bonuses, including company stock and options. directly owns 3.45% of the company’s shares, worth R$2.97B. The average tenure of the management team and the board of directors is 2.6 years and 4.3 years respectively.
Key information
John Oyler
Chief executive officer
US$18.9m
Total compensation
CEO salary percentage | 4.6% |
CEO tenure | 14.3yrs |
CEO ownership | 3.4% |
Management average tenure | 2.6yrs |
Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | US$19m | US$871k | -US$882m |
Sep 30 2023 | n/a | n/a | -US$959m |
Jun 30 2023 | n/a | n/a | -US$2b |
Mar 31 2023 | n/a | n/a | -US$2b |
Dec 31 2022 | US$18m | US$800k | -US$2b |
Sep 30 2022 | n/a | n/a | -US$2b |
Jun 30 2022 | n/a | n/a | -US$2b |
Mar 31 2022 | n/a | n/a | -US$2b |
Dec 31 2021 | US$17m | US$740k | -US$1b |
Sep 30 2021 | n/a | n/a | -US$1b |
Jun 30 2021 | n/a | n/a | -US$1b |
Mar 31 2021 | n/a | n/a | -US$1b |
Dec 31 2020 | US$14m | US$696k | -US$2b |
Sep 30 2020 | n/a | n/a | -US$2b |
Jun 30 2020 | n/a | n/a | -US$1b |
Mar 31 2020 | n/a | n/a | -US$1b |
Dec 31 2019 | US$13m | US$675k | -US$949m |
Sep 30 2019 | n/a | n/a | -US$829m |
Jun 30 2019 | n/a | n/a | -US$665m |
Mar 31 2019 | n/a | n/a | -US$737m |
Dec 31 2018 | US$28m | US$650k | -US$674m |
Sep 30 2018 | n/a | n/a | -US$505m |
Jun 30 2018 | n/a | n/a | -US$243m |
Mar 31 2018 | n/a | n/a | -US$147m |
Dec 31 2017 | US$10m | US$515k | -US$93m |
Compensation vs Market: John's total compensation ($USD18.93M) is above average for companies of similar size in the BR market ($USD5.93M).
Compensation vs Earnings: John's compensation has increased whilst the company is unprofitable.
CEO
John Oyler (55 yo)
14.3yrs
Tenure
US$18,925,730
Compensation
Mr. John V. Oyler Co-Founded BeiGene, Ltd. and has been its Chief Executive Officer since 2010. Mr. Oyler Co-founded BioDuro, LLC and served as its Chief Executive Officer and President from 2005 to 2009....
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 14.3yrs | US$18.93m | 3.45% $ 3.0b | |
President & COO | 6yrs | US$11.00m | 0.060% $ 51.6m | |
Co-Chairman of Scientific Advisory Board & Non-Executive Director and Co-Founder | 14.3yrs | US$4.42m | 0.77% $ 663.4m | |
CFO & Principal Financial Officer | 2.9yrs | US$6.07m | 0.0055% $ 4.7m | |
General Counsel & Senior VP | 1.8yrs | US$4.05m | 0.0014% $ 1.2m | |
Global Head of R&D | no data | US$7.32m | 0.10% $ 87.4m | |
VP & Chief Accounting Officer | less than a year | no data | no data | |
Head of Investor Relations | no data | no data | no data | |
Chief Compliance Officer | less than a year | no data | no data | |
Senior VP & Head of Public Affairs - Greater China | 3.3yrs | no data | no data | |
Senior Vice President of Strategy & Corporate Development | 1.3yrs | no data | no data | |
Senior VP & Chief Medical Officer for Solid Tumors | 2.3yrs | no data | no data |
2.6yrs
Average Tenure
53.5yo
Average Age
Experienced Management: B1GN34's management team is considered experienced (2.6 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 13.6yrs | US$18.93m | 3.45% $ 3.0b | |
Co-Chairman of Scientific Advisory Board & Non-Executive Director and Co-Founder | 8.3yrs | US$4.42m | 0.77% $ 663.4m | |
Acting Head of Medicinal Chemistry & Member of Scientific Advisory Board | 3.1yrs | no data | no data | |
Independent Non-Executive Director & Member of the Scientific Advisory Committee | 9.1yrs | US$481.92k | 0.0025% $ 2.1m | |
Independent Non-Executive Director | 11.3yrs | US$480.80k | 0.20% $ 168.6m | |
Independent Non-Executive Director & Member of Scientific Advisory Committee | 3.8yrs | US$501.55k | 0.0013% $ 1.1m | |
Independent Non-Executive Director | 4.3yrs | US$513.15k | 0.00057% $ 490.6k | |
Co-Chairman of Scientific Advisory Committee & Independent Non-Executive Director | 2.3yrs | US$491.67k | 0.0012% $ 1.1m | |
Independent Non-Executive Director | less than a year | no data | 0% $ 0 | |
Independent Lead Director | 9.6yrs | US$487.05k | 0.0025% $ 2.1m | |
Member of Scientific Advisory Board & Independent Non-Executive Director | 2.3yrs | US$510.55k | 0.0012% $ 1.1m |
4.3yrs
Average Tenure
64yo
Average Age
Experienced Board: B1GN34's board of directors are considered experienced (4.3 years average tenure).